NO20043717L - Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic - Google Patents

Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic

Info

Publication number: NO20043717L
Authority: NO; Norway
Prior art keywords: dihydrotiaphenanthrene; diagnostic; drug; preparation; guanidines
Prior art date: 2002-02-07

Application number

NO20043717A

Other languages

Norwegian (no)

Inventor

Peter Below

Heinz-Werner Kleemann

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-07

Filing date

2004-09-06

Publication date

2004-11-03

2004-09-06 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2004-11-03 Publication of NO20043717L publication Critical patent/NO20043717L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/10—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Cardiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20043717A 2002-02-07 2004-09-06 Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic NO20043717L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10204989A DE10204989A1 (en)	2002-02-07	2002-02-07	Dihydro-thia-phenanthren-carbonyl-guanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
PCT/EP2003/000653 WO2003066620A1 (en)	2002-02-07	2003-01-23	Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent

Publications (1)

Publication Number	Publication Date
NO20043717L true NO20043717L (en)	2004-11-03

Family

ID=27618378

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043717A NO20043717L (en)	2002-02-07	2004-09-06	Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic

Country Status (24)

Country	Link
EP (1)	EP1474414B1 (en)
JP (1)	JP4410564B2 (en)
KR (1)	KR20040096555A (en)
CN (1)	CN1319963C (en)
AR (1)	AR038393A1 (en)
AT (1)	ATE380805T1 (en)
AU (1)	AU2003208337A1 (en)
BR (1)	BR0307495A (en)
CA (1)	CA2475093A1 (en)
CO (1)	CO5601008A2 (en)
DE (2)	DE10204989A1 (en)
HR (1)	HRP20040721A2 (en)
HU (1)	HUP0402595A2 (en)
MA (1)	MA27171A1 (en)
MX (1)	MXPA04007476A (en)
NO (1)	NO20043717L (en)
NZ (1)	NZ534536A (en)
PE (1)	PE20030963A1 (en)
PL (1)	PL370271A1 (en)
RS (1)	RS69204A (en)
RU (1)	RU2306311C2 (en)
TW (1)	TWI268927B (en)
WO (1)	WO2003066620A1 (en)
ZA (1)	ZA200406015B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200614995A (en)	2004-11-10	2006-05-16	Nicholas Piramal India Ltd	Tricyclic guanidine derivatives as sodium-proton exchange inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60262887A (en) *	1984-06-11	1985-12-26	Mitsubishi Chem Ind Ltd	liquid crystal composition
GB8505756D0 (en) *	1985-03-06	1985-04-11	Erba Farmitalia	Tricyclic dibenzo condensed derivatives
US4948806A (en) *	1988-03-30	1990-08-14	Warner-Lambert Company	Antihyperlipidemic and antiatherosclerotic compounds and compositions
DE19601303A1 (en) *	1996-01-16	1997-07-17	Boehringer Ingelheim Kg	Novel benzoylguanidine derivatives, process for their preparation and their use in the manufacture of medicaments
EP1180029A4 (en) *	1999-04-23	2002-10-02	Bristol Myers Squibb Co	Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
DE10001879A1 (en) *	2000-01-19	2001-07-19	Aventis Pharma Gmbh	New benzoylguanidine derivatives are Na+/H+ exchange inhibitors useful for the treatment and prevention of e.g. ischemic disorders, infarction, arrhythmia, angina pectoris and stroke

2002
- 2002-02-07 DE DE10204989A patent/DE10204989A1/en not_active Withdrawn
2003
- 2003-01-23 JP JP2003565993A patent/JP4410564B2/en not_active Expired - Fee Related
- 2003-01-23 PL PL03370271A patent/PL370271A1/en not_active Application Discontinuation
- 2003-01-23 RS YU69204A patent/RS69204A/en unknown
- 2003-01-23 AU AU2003208337A patent/AU2003208337A1/en not_active Abandoned
- 2003-01-23 BR BR0307495-1A patent/BR0307495A/en not_active IP Right Cessation
- 2003-01-23 WO PCT/EP2003/000653 patent/WO2003066620A1/en not_active Ceased
- 2003-01-23 CN CNB038035502A patent/CN1319963C/en not_active Expired - Fee Related
- 2003-01-23 DE DE50308787T patent/DE50308787D1/en not_active Expired - Lifetime
- 2003-01-23 AT AT03706373T patent/ATE380805T1/en not_active IP Right Cessation
- 2003-01-23 KR KR10-2004-7012241A patent/KR20040096555A/en not_active Withdrawn
- 2003-01-23 NZ NZ534536A patent/NZ534536A/en unknown
- 2003-01-23 EP EP03706373A patent/EP1474414B1/en not_active Expired - Lifetime
- 2003-01-23 CA CA002475093A patent/CA2475093A1/en not_active Abandoned
- 2003-01-23 RU RU2004126854/04A patent/RU2306311C2/en not_active IP Right Cessation
- 2003-01-23 HR HR20040721A patent/HRP20040721A2/en not_active Application Discontinuation
- 2003-01-23 MX MXPA04007476A patent/MXPA04007476A/en active IP Right Grant
- 2003-01-23 HU HU0402595A patent/HUP0402595A2/en unknown
- 2003-01-30 TW TW092102087A patent/TWI268927B/en not_active IP Right Cessation
- 2003-02-05 AR ARP030100363A patent/AR038393A1/en unknown
- 2003-02-05 PE PE2003000136A patent/PE20030963A1/en not_active Application Discontinuation
2004
- 2004-07-27 MA MA27802A patent/MA27171A1/en unknown
- 2004-07-28 ZA ZA200406015A patent/ZA200406015B/en unknown
- 2004-08-06 CO CO04076743A patent/CO5601008A2/en not_active Application Discontinuation
- 2004-09-06 NO NO20043717A patent/NO20043717L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
TWI268927B (en)	2006-12-21
HUP0402595A2 (en)	2005-04-28
ZA200406015B (en)	2005-11-14
MXPA04007476A (en)	2004-11-10
RU2306311C2 (en)	2007-09-20
JP2005517015A (en)	2005-06-09
PE20030963A1 (en)	2004-01-12
CO5601008A2 (en)	2006-01-31
EP1474414A1 (en)	2004-11-10
NZ534536A (en)	2006-02-24
MA27171A1 (en)	2005-01-03
JP4410564B2 (en)	2010-02-03
BR0307495A (en)	2004-12-28
DE10204989A1 (en)	2003-08-21
CN1630649A (en)	2005-06-22
EP1474414B1 (en)	2007-12-12
DE50308787D1 (en)	2008-01-24
HRP20040721A2 (en)	2005-06-30
AR038393A1 (en)	2005-01-12
ATE380805T1 (en)	2007-12-15
CN1319963C (en)	2007-06-06
RS69204A (en)	2006-12-15
CA2475093A1 (en)	2003-08-14
PL370271A1 (en)	2005-05-16
HK1073656A1 (en)	2005-10-14
KR20040096555A (en)	2004-11-16
WO2003066620A1 (en)	2003-08-14
AU2003208337A1 (en)	2003-09-02
TW200404792A (en)	2004-04-01
RU2004126854A (en)	2006-01-27

Publication	Publication Date	Title
DK1549341T3 (en)	2009-07-06	Against tissue factor, antibodies directed as anticoagulants
DK1592457T3 (en)	2012-10-22	FOLATE-VINBLASTIN CONJUGATE AS MEDICINAL
DK3133070T3 (en)	2019-11-11	ELIGLUSTATE (GENZ 112638) AS A INHIBITOR OF GLUCOSYL CERAMIDE SYNTHESIS FOR USE IN A PROCEDURE FOR TREATING A FACTORY OR GAUCH'S DISEASE, WHICH METHOD OF METHODS INCLUDES THE ADMINISTRATION OF THE INDIVIDUAL
NO20040356L (en)	2004-03-19	Indanacetic acid derivatives and their use as pharmaceutical agents, intermediates and methods of preparation.
NO20044322L (en)	2004-10-12	Benzoxanone-derived compounds, their preparation and use as a drug
NO20054555D0 (en)	2005-10-04	Pharmaceutical preparations comprising acid stabilized insulin
NO20054329D0 (en)	2005-09-20	Adamantan derivatives, processes for their preparation, and pharmaceutical compositions which include them
DK1453810T3 (en)	2009-07-20	Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as a drug containing the same
NO20054876D0 (en)	2005-10-21	Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as drug and drug containing such compounds
FI20030383A0 (en)	2003-03-14	Process for the preparation of the catalyst
NO20022801D0 (en)	2002-06-12	Substituted norbornylamino derivatives, process for their preparation, their use as a drug or diagnostic as well as drugs containing these
DK1838315T3 (en)	2014-06-16	SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, METHOD OF PREPARING IT, THEIR USE AS MEDICINE AND MEDICINES CONTAINING THEM
DE602005014280D1 (en)	2009-06-10	PROCESS FOR THE PREPARATION OF Ä1,4,5Ü-OXADIAZEPINE DERIVATIVES
DK1513834T3 (en)	2006-07-17	Substituted thiophenes, methods for their preparation, their use as a drug or diagnostic, and drug containing them
NO20043717L (en)	2004-11-03	Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic
DK1816121T3 (en)	2008-06-16	9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
ITTO20030850A1 (en)	2005-04-30	PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DICLORO-BENZOTRIFLORURO.
ITMI20031994A1 (en)	2005-04-16	PROCEDURE FOR THE PREPARATION OF FLUDARABINA FOSFATO
DK1685096T3 (en)	2007-10-22	Pentafluorosulfanyl-benzoylguanidines, methods of their preparation, their use as a drug or diagnostic, as well as drugs containing them
ITMI20041920A1 (en)	2005-01-11	PROCESS FOR THE PREPARATION OF N, N-DIISOPROPYL-3-2-HYDROXY-5-METHYLPHENYL-3-PHENYL-PROPABAMMINE
PL1853220T5 (en)	2023-08-07	Method for the preparation of NSAID-containing lozenges, their compositions, their medical use
IT1338456B1 (en)	2007-03-12	PROCEDURE FOR THE PREPARATION OF ALCHILUREE DA O, D-DIMETHYL DICIOCARBONATE
ITMI20030018A1 (en)	2004-07-10	PROCEDURE FOR THE PREPARATION OF SINGLE COMPOUNDS
DK1461034T3 (en)	2007-03-26	Substituted imidazolidines, processes for their preparation, their use as a drug or diagnostic, as well as drugs containing them
ITMI20030019A1 (en)	2004-07-10	PROCEDURE FOR THE PREPARATION OF SINGLE COMPOUNDS

Legal Events

Date	Code	Title	Description
2008-08-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application